0.00
+13.79%
Close of 9 Nov 2026, in USD
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About Avvaa World Health Care Products
Its shares trade under the ticker AVVH. It has been listed since 23 February 2001. In the fiscal year to 31 May 2026, it reported revenue of $157,859 and a net loss of $18,511. At that date it held total assets of $1.6m and shareholders' equity of $120,377.
avVaa World Health Care Products, Inc. is a biotechnology company. The company is headquartered in Lumby, British Columbia. The company went IPO on 2001-02-23. The firm provides all-natural, therapeutic skin care products. The firm manages the manufacturing, distribution, marketing and sale of health-care products to the countries. The firm's provides medically safe, natural, non-toxic health-care products and products that treat skin abnormalities as well as enhance the natural clarity and texture of healthy skin. The firm has the distribution rights for European skin care products, which are developed to treat the symptoms of skin diseases including eczema, psoriasis and acne. The firm intends to manufacture and market over-the-counter the Neuroskin line of products through mass marketing food and drug channels in the United States. The three flagship core products of the Neuroskin lines are Food and Drug Administration compliant.
Figures and description from our data supplier, not checked against the company's own report.
Company facts
- Sector
- N/A
- Industry
- N/A
- Listed since
- 23 Feb 2001
- Employees
- 2
Leadership
Pay as last reported
- Mr. Miguel SanchezPresident, Chief Executive Officer, Director, since 2021
- Ruth BrennanChief Financial Officer, Director, since 2010$78,000
- Mr. Ankit AminVice President, Director, since 2021
- Mr. Patrice AshiofuVice President, Director, since 2021
- Mr. Luis BeitaVice President, Director, since 2021
- Mr. Jean GarzonTreasurer, Director, since 2021
- Mr. Carey CooleySecretary, Director, since 2021
- MR. Zang LiDirector
- Dr. Jun WangDirector
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 0
- Environment
- 0
- Social
- 0
- Governance
- 0
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- AVVaa World Health Care Products Inc is known for producing high-quality healthcare products. This helps to build trust among customers and positions the company as a reliable and reputable brand in the market.
- The company has established a robust distribution network that enables its products to reach a wide range of markets globally. This allows AVVaa to penetrate new markets efficiently and ensures a continuous supply of its products.
- AVVaa offers a diverse range of healthcare products, catering to various needs and preferences of consumers. This wide product portfolio provides the company with a competitive edge and allows it to capture a larger share of the market.
Weaknesses
- Despite its strong distribution network, AVVaa World Health Care Products Inc still faces challenges in expanding its global presence. It may struggle to establish a strong market presence in certain regions, limiting its potential customer base.
- The company relies on a few key suppliers for its raw materials and components. Any disruption in the supply chain from these suppliers can significantly impact AVVaa's production and ability to meet customer demand.
- AVVaa may face difficulties in building brand awareness, especially when competing with well-established healthcare product manufacturers. This could affect its ability to attract new customers and gain market share.
Opportunities
- The increasing awareness and preference for natural/herbal healthcare products provide AVVaa with an opportunity to expand its product range and tap into this growing market segment. This allows the company to attract more health-conscious consumers.
- Rapid advancements in technology offer AVVaa the opportunity to enhance its production processes, improve product quality, and develop more innovative healthcare solutions. Embracing and leveraging these technologies can give the company a competitive advantage.
- AVVaa can explore expansion into emerging markets where the demand for healthcare products is rising. By identifying and targeting these markets, the company can enter new territories and diversify its customer base, increasing its market share.
Threats
- The healthcare products market is highly competitive, with numerous established brands and new entrants vying for market share. AVVaa World Health Care Products Inc faces the constant threat of competitors offering similar or better products at competitive prices.
- Strict regulations and compliances in the healthcare industry can pose challenges for AVVaa in terms of product development, manufacturing, and marketing. Non-compliance may lead to penalties, product recalls, and damage to the company's reputation.
- Fluctuations in the global economy and instability in financial markets can impact AVVaa's business operations, consumer purchasing power, and overall demand for healthcare products. Economic downturns may result in reduced sales and revenue for the company.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.